Affirm stock remains a "Buy" after the recent surge higher. Learn more about AFRM's impressive GMV growth, GAAP profitability ...

ORIX (IX) stock remains a "Buy" as earnings accelerate and ROE expands, supported by asset disposals and cash returns. Here's ...

IBM has transformed into a higher-quality, more predictable business with a focus on recurring software revenue and ...

"Our first quarter results reflect the negative impact of the previously disclosed delay in an anticipated contract extension with the Department of War," said President, CEO & Director Anthony Scott, ...

Mark said the company "updated our full year 2026 guidance for revenue to be in the range of $165 million to $170 million and adjusted EBITDA to be in the range of $45 million to $50 million," and ...

Good day, ladies and gentlemen, and welcome to Intrusion, Inc.'s First Quarter 2026 Earnings Conference Call and webcast. [Operator Instructions] Please note, this conference call is being recorded.

Novo Nordisk (NVO) surged 25% on Ozempic/Wegovy pill launches, FDA approvals, and low valuation. See here for more details.

Goldman Sachs BDC suffered a 50% Y/Y drop in net investment income, missing analyst expectations and triggering a ...

Q1 2026 Earnings Call May 14, 2026 4:30 PM EDTCompany ParticipantsJin Kang - CEO & DirectorJason Holloway - President ...

Q1 2026 recovery lifts fundamentals as CF/FP segments grow and backlog builds. Read here for a more detailed analysis.

Q1 2026 Earnings Call May 14, 2026 5:30 PM EDTCompany ParticipantsJohanna Gonzalez - Director of Investor Relations ...

UnitedHealth (UNH) rated a slim Buy after 59% rebound on strong Q1, higher EPS guide and buybacks; learn key DOJ/PBM risks ...